Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 9.18 CHF with a low forecast of 3.03 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
3.03 CHF
42% Downside
Average
Price Target
9.18 CHF
77% Upside
Highest
Price Target
15.75 CHF
203% Upside
Molecular Partners AG Competitors:
Price Targets
CDTX
Cidara Therapeutics Inc
118% Upside
AVTE
Aerovate Therapeutics Inc
10% Downside
ADAG
Adagene Inc
353% Upside
MRKR
Marker Therapeutics Inc
341% Upside
INCY
Incyte Corp
6% Downside
BONEX
Bonesupport Holding AB
5% Downside
145020
Hugel Inc
20% Upside
BIIB
Biogen Inc
62% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 42%.

-16%
Past Growth
42%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
9.18 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 9.18 CHF with a low forecast of 3.03 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
42%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 42%.

Back to Top